HPBCD in liquid formulations: a systematic study of physical properties and surfactant compatibility
The researchers of TEVA (USA) explored the role of 2-hydroxypropyl-β-cyclodextrin (HPβCD) as an excipient in liquid formulations by evaluating its
A forum for researchers, students and applicants in the field of cyclodextrin technology
The researchers of TEVA (USA) explored the role of 2-hydroxypropyl-β-cyclodextrin (HPβCD) as an excipient in liquid formulations by evaluating its
APGI and Evonik Health Care are are organizing the joint Information Day 2022. The event will take place on May
CPhI Japan will be held on01-30 April online and 14 – 16 April 2021 live in Tokyo, Big Sight complex.